Welcure Drugs & Pharmaceuticals Ltd Management Discussions

Industry Structure & Developments: The pharmaceutical industry continues to witness significant growth and transformation, driven by technological advancements, increased healthcare awareness, and rising global demand for innovative treatments. Despite its promising outlook, the industry remains highly competitive, with players constantly investing in research and development (R&D) to gain a competitive edge and bring novel therapies to market.

Regulatory frameworks across different regions are evolving, with a growing emphasis on patient safety, data transparency, and accelerated approval pathways, especially for lifesaving or rare disease treatments. The integration of digital health technologies, artificial intelligence, and precision medicine is also reshaping drug development and delivery processes.

Moreover, the post-pandemic era has reinforced the importance of strong supply chain systems, local manufacturing capabilities, and global collaborations. Mergers and acquisitions, strategic partnerships, and licensing deals continue to be key growth strategies for both established and emerging companies.

In summary, while the pharmaceutical sector holds significant potential for innovation and expansion, companies must navigate increasing competition, regulatory complexity, and the need for sustainable, patient-centric solutions.

Opportunities & Threats:

Opportunities:

1) Growing Global Healthcare Demand

• Rising life expectancy, aging populations, and the increasing burden of chronic diseases (e.g., diabetes, cardiovascular diseases, cancer) are boosting long-term demand for pharmaceutical products.

2) Technological Advancements & Innovation

• Emerging technologies such as artificial intelligence, gene therapy, mRNA platforms, and precision medicine are enabling the development of more effective and targeted treatments.

3) Expansion in Emerging Markets

• Developing countries in Asia, Africa, and Latin America are experiencing improved healthcare infrastructure and increased access to medicines, offering significant growth potential.

4) Biosimilars and Generic Drug Market

• With numerous blockbuster drugs losing patent protection, there are strong opportunities for companies to introduce cost-effective generics and biosimilars.

5) Digital Health & Remote Care Integration

• The integration of digital technologies, such as telemedicine, wearable health devices, and e-prescriptions, is enhancing patient engagement and operational efficiency.

6) Preventive Healthcare and Wellness Products

• Growing awareness around health and wellness is driving demand for preventive care, including vaccines, dietary supplements, and nutraceuticals.

Threats:

1) Intense Market Competition and Price Pressure

• The pharmaceutical sector, particularly the generics segment, faces strong competition, leading to reduced pricing power and thinner margins.

2) Stringent and Evolving Regulatory Environment

• Global operations must comply with complex and varied regulatory requirements, and failure to meet standards can result in bans, recalls, or penalties.

3) High R&D Costs and Long Development Timelines

• Developing new drugs is time-consuming and costly, with no assurance of commercial success, putting financial strain on companies.

4) Patent Expirations and Loss of Exclusivity

• When patents expire, revenues from high-performing drugs can decline rapidly due to the entry of generic competitors.

5) Supply Chain Vulnerabilities

• Heavy dependence on specific countries for raw materials (e.g., APIs) makes the industry vulnerable to disruptions from geopolitical tensions, trade restrictions, or pandemics.

6) Public Scrutiny and Pricing Regulations

• Growing concerns about drug affordability and pricing practices may lead to policy changes and increased pressure on pharmaceutical companies to justify prices.

7) Emerging Diseases and Antimicrobial Resistance

• Constantly evolving pathogens and growing resistance to antibiotics require continuous innovation, often without immediate commercial return.

Segment-Wise Performance:

The company operates exclusively in a single business segment: the trading of medical products. This singular focus underscores the companys strategic emphasis on streamlining operations and leveraging specialized expertise in the procurement and distribution of pharmaceutical goods.

The companys revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets. This concentrated approach allows the company to maintain a high level of operational efficiency and responsiveness to market demands.

Outlook:

1) Our company is strategically positioned to capitalize on the growing demand for medical products. We aim to enhance our product portfolio by incorporating innovative solutions that address unmet medical needs.

Strategic Initiatives;

• Product Innovation: Investing in research and development to introduce new medical products that meet the evolving needs of healthcare providers and patients.

• Market Expansion: Exploring new geographical markets and strengthening our distribution networks to increase market share.

• Operational Efficiency: Implementing advanced technologies and streamlined processes to enhance productivity and reduce operational costs.

Risks & Concerns:

While our company remains committed to delivering high-quality medical products and services, we acknowledge several risks and concerns inherent to the industry. Proactively identifying and managing these risks is essential to ensure sustained growth and stakeholder confidence.

• Supply Chain Disruptions:

Our operations depend on a complex global supply chain for sourcing medical products. Geopolitical tensions, natural disasters, or pandemics can disrupt this supply chain, leading to delays, increased costs, or shortages. Such disruptions can affect our ability to meet customer demands and maintain inventory levels.

• Counterfeit Products and Quality Assurance:

The proliferation of counterfeit medical products poses a significant threat to patient safety and company reputation. Ensuring the authenticity and quality of products through stringent quality control measures and supplier verification is paramount. Failure to do so can result in legal liabilities and loss of customer trust.

• Market Competition and Pricing Pressures:

The medical products market is highly competitive, with pressure on pricing and margins. Maintaining a balance between cost competitiveness and product quality is challenging. Strategic partnerships and continuous innovation are necessary to stay ahead in the market.

Internal Control Systems & their Adequacy:

The Company believes in systematic working and placing appropriate internal control systems and checks. Proper checks and systems are in place and regular reviews are held by the Head of Department and Senior Management to check that the systems and controls are adhered. The reviews also prescribe changes wherever required.

MATERIAL DEVELOPMENT IN HUMAN RESOURCES /INDUSTRIAL RELATIONS FRONT, INCLUDING THE NUMBER OF PEOPLE EMPLOYED:

Human resource has always been one of the most valued stakeholders and a key differentiator for Welcure Drugs & Pharmaceuticals Limited. The underlying principle is that workers and staff at all levels are equally instrumental for attaining the Companys goals. The Company strongly believes in the policy of hiring the right talent for the right position at the right time, with a focus to improve employee productivity.

Welcure believes that people are the backbone of the company. The Company has meritocratic culture and provides a conducive workplace for all. Occupational health and safety of employee is ensured at all times. The company focuses on the learning and professional development of its employees. Training programmes are regularly conducted to update their skills and apprise them of latest techniques. To enable the organisation to attain its full potential, it is imperative for us to create and maintain an ideal work culture thus creating an engaged and skilled workforce capable of delivering on the commitments to our stakeholders and in the process, making us ‘Future Ready- structurally, financially and culturally. Senior Management is easily accessible for counseling and redressal of grievances if any. The HR Department strives to maintain and promote harmony and coordination amongst Workers, Staff, and Members of the Senior Management.

Cautionary statement:

Statements in the Management Discussion and Analysis describing the Companys objectives, projections, estimates and expectations are "forward-looking statements" within

the meaning of applicable securities laws and regulations. Actual results may differ materially from those expressed or implied. Important factors that could make a difference to the Companys operations include economic conditions affecting demand/supply and price conditions in the domestic and overseas markets in which the Company operates; changes in the Government regulations; tax laws and other statutes and incidental factors.

	For and on behalf of the Board
	Welcure Drugs & Pharmaceuticals Limited
Place: New Delhi	Sd/- Sd/- Chintan Didawala Ganpat Ravi Thakor Managing Director Director DIN:11088268 DIN:11210729
Date: 02.09.2025